TheProfitWatch

MAIA - MAIA Biotechnology, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.89 0.04 (4.05%) 0.0 (0.0%) 0.01 (1.02%) 0.01 (1.24%) --- 0.04 (4.05%) 0.05 (5.82%) 0.05 (5.82%)

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.18
Diluted EPS:
-0.18
Basic P/E:
-5.1289
Diluted P/E:
-5.1289
RSI(14) 1m:
56.94
VWAP:
0.92
RVol:

Events

Period Kind Movement Occurred At

Related News